Viking Therapeutics (VKTX) had the highest return between April 1, 2022 and March 31, 2023 by a mid-cap US stock, returning 453.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 4/1/2022 - 3/31/2023 | 453.16% |
Torm PLC Class A (TRMD) | 4/1/2022 - 3/31/2023 | 314.12% |
Verona Pharma PLC ADR (VRNA) | 4/1/2022 - 3/31/2023 | 296.84% |
ELF Beauty (ELF) | 4/1/2022 - 3/31/2023 | 215.15% |
New Oriental Education & Technology (EDU) | 4/1/2022 - 3/31/2023 | 213.9% |
Immunovant (IMVT) | 4/1/2022 - 3/31/2023 | 179.46% |
TransMedics (TMDX) | 4/1/2022 - 3/31/2023 | 179.45% |
Akero Therapeutics (AKRO) | 4/1/2022 - 3/31/2023 | 166.81% |
Scorpio Tankers (STNG) | 4/1/2022 - 3/31/2023 | 164.85% |
Modine Manufacturing (MOD) | 4/1/2022 - 3/31/2023 | 152.19% |
International Seaways (INSW) | 4/1/2022 - 3/31/2023 | 149.03% |
Madrigal Pharmaceuticals (MDGL) | 4/1/2022 - 3/31/2023 | 144.86% |
Belite Bio Inc ADR (BLTE) | 4/1/2022 - 3/31/2023 | 139.2% |
Biohaven Pharmaceutical (BHVN) | 4/1/2022 - 3/31/2023 | 127.67% |
Powell Industries (POWL) | 4/1/2022 - 3/31/2023 | 125.85% |
Miniso Group Holding (MNSO) | 4/1/2022 - 3/31/2023 | 120.36% |
Arcellx (ACLX) | 4/1/2022 - 3/31/2023 | 120.23% |
Vita Coco (COCO) | 4/1/2022 - 3/31/2023 | 120.2% |
Vista Oil Gas ADR (VIST) | 4/1/2022 - 3/31/2023 | 118.43% |
Impinj (PI) | 4/1/2022 - 3/31/2023 | 111.52% |
MoonLake Immunotherapeutics (MLTX) | 4/1/2022 - 3/31/2023 | 111.15% |
Wave Life Sciences (WVE) | 4/1/2022 - 3/31/2023 | 110.19% |
Agilysys (AGYS) | 4/1/2022 - 3/31/2023 | 104.88% |
Tidewater (TDW) | 4/1/2022 - 3/31/2023 | 103.13% |
TAL Education (TAL) | 4/1/2022 - 3/31/2023 | 100.94% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
